In exercise of the powers conferred under rule 8 of the Drugs and Cosmetics Rules, 1945, the Central Government

## Policy Analysis Report: Notification S.O. 189(E) - Authorization of Certificate Signatory at National Institute of Biologicals, NOIDA **1. Executive Summary:** This report analyzes Notification S.O. 189(E) issued by the Ministry of Health and Family Welfare, Department of Health and Family Welfare, on January 15, 2021. This notification constitutes an *amendment* relating to the Drugs and Cosmetics Rules, 1945. The core purpose of this amendment is to authorize Dr. J. P. Prasad, Deputy Director-Quality Control, National Institute of Biologicals (NIB), NOIDA, to sign certificates on behalf of the Director, NIB, NOIDA. This authorization is effective until further notice. This report details the background, changes, target audience, and expected outcomes of this amendment. **2. Introduction:** This report aims to provide an informative analysis of Notification S.O. 189(E), focusing on the specific changes it introduces regarding certificate signing authority at the National Institute of Biologicals, NOIDA. This analysis is solely based on the information provided in the notification text. **3. Policy Overview:** This notification is an *amendment* to the Drugs and Cosmetics Rules, 1945. * **Core Objective(s) (inferred):** The primary objective of this amendment is to delegate the authority to sign certificates at the National Institute of Biologicals, NOIDA, to Dr. J.P. Prasad, likely to streamline operations and ensure continuity. **4. Background and Rationale:** This notification amends the Drugs and Cosmetics Rules, 1945, which implies that changes may be needed to adapt to changing times or operational requirements in the administration and implementation of drug and cosmetic regulations. The amendment likely addresses a practical need to ensure the timely issuance of certificates by authorizing a deputy director to sign on behalf of the director. It's possible the Director was frequently unavailable, or it was deemed more efficient to distribute signing authority. The likely reason *for this specific amendment* is to ensure continuity and efficiency in the certification process at the NIB, NOIDA, by providing an alternative authorized signatory. **5. Key Provisions / Changes:** This notification introduces the following specific change: * **Specific Part of the Original Policy Being Changed:** This notification invokes Rule 8 of the Drugs and Cosmetics Rules, 1945. This implies this rule likely pertains to authorization and delegation of duties regarding implementation of these rules. * **New Rule/Provision:** Dr. J. P. Prasad, Deputy Director-Quality Control, National Institute of Biologicals, NOIDA, is authorized to sign certificates on behalf of the Director, National Institute of Biologicals, NOIDA. This authorization is valid until further notice. * **Difference/Effect of Change:** Previously, it is reasonable to assume that only the Director of the NIB, NOIDA, was authorized to sign certificates. This change allows Dr. Prasad to sign, effectively delegating authority and potentially expediting the certification process. This may reduce potential bottlenecks and ensure continued operations even in the Director's absence. **6. Target Audience and Stakeholders:** Based on the provided text, the direct target audience and stakeholders affected by this amendment include: * **National Institute of Biologicals, NOIDA:** Specifically, the Director, Deputy Director-Quality Control (Dr. J.P. Prasad), and staff involved in the certification process. * **Ministry of Health and Family Welfare:** As the issuing authority. * **Pharmaceutical and Biologics industry:** Entities requiring certifications from the National Institute of Biologicals, NOIDA. This change will directly impact the timeliness and efficiency of obtaining necessary certification. **7. Implementation Aspects (Inferred):** * **Responsible Agency/Bodies:** The Central Government (Ministry of Health and Family Welfare) and the National Institute of Biologicals, NOIDA, are responsible for implementing this amendment. * **Timelines/Procedures:** The authorization is effective from January 15, 2021, and remains valid "till further order." No specific procedures are outlined in the text beyond the authorization itself. Internal procedures within the NIB, NOIDA, will likely need to be updated to reflect this change in signatory authority. The "till further order" clause introduces uncertainty in how long this delegation will be in place. **8. Expected Outcomes / Impact of Changes:** The likely intended outcome of this amendment is to: * **Improve efficiency:** Streamline the certification process at the National Institute of Biologicals, NOIDA, by providing an alternate signatory. * **Ensure continuity:** Prevent delays in certification due to the Director's potential unavailability. * **Maintain operational effectiveness:** Ensure the timely issuance of certificates, which is critical for the pharmaceutical and biologics industry. This change will likely have a positive impact on the industry by streamlining the process. **9. Conclusion:** Notification S.O. 189(E) is a focused amendment to the Drugs and Cosmetics Rules, 1945, designed to delegate signing authority at the National Institute of Biologicals, NOIDA. By authorizing Dr. J. P. Prasad to sign certificates on behalf of the Director, the amendment aims to improve efficiency, ensure operational continuity, and reduce potential delays in the certification process. While the notification's scope is limited, its impact on the pharmaceutical and biologics industry, which relies on timely certifications from NIB, NOIDA, is likely to be positive. The "till further order" caveat means the industry should monitor for future notifications that might rescind or modify this delegation of authority.

Key Entities Referenced